Pay in 4 interest-free payments of $5.49 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Advanced Treatments to Treat Obesity and High Blood Sugar The GLP-1 market comprises glucagon-like peptide-1 (GLP-1) receptor agonist drugs, either in the form of orally available drugs, used mainly for the treatment of type-2 diabetes, obesity, and conditions such as heart ailments and chronic kidney ailments
Formulating products that cater to a young and health-conscious demographic can also be key here, with convenience formats such as snacks and mini meals likely to capture the interest of GLP-1 consumers
Yasuda, S
Diabetes Care 2014;37:2159-67
The Centers for Disease Control and Prevention reports the obesity prevalence among U.S
US$ 20.64
US$ 21.76
US$ 20.98
US$ 22.32
US$ 25.82
US$ 28.04
US$ 20.71
US$ 26.38
US$ 27.87
